Holy Stone Healthcare Co., Ltd.

NT$6.10As of Sun 8 Nov 2026, 12:00 UTC
TPEx:4194Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (11.00%)
Div yield —
ROE (67.24%)
Biotechnology
Beta (5Y) 0.80
PE TTM —
TSR TTM (32.89%)
Mkt cap NT$890.4M
ROIC (41.33%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$7.40
21.24%
29.31%
Sell 0|6|1|4|7
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.06
0.06
0.06
0.06
15.72%
(1.57%)
(2.73%)
4.05%
RevenueNT$M
106.0
111.9
110.4
114.4
9.03%
16.32%
15.43%
13.87%
Peers (US$27.03M)
Cap (US$)
PE
28.28M
—
27.69M
18.25x
26.82M
—
Capital
TTM
5Y
10Y
Leveragex
3.374
0.637
0.611
EBIT/Intx
1.031
0.262
0.280
Own earn%
(55.57)
58.84
61.59
Sh yield%
32.65
40.97
44.24
Owners
Insiders/Inst%
12.62
79.07
Short interest%
5.22
SBC / revenue%
3.77
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
1–9
$1 testx
−0.1
Incr. ROIC%
2